{"id":1430,"date":"2013-05-07T13:28:39","date_gmt":"2013-05-07T12:28:39","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=1430"},"modified":"2013-05-07T13:28:39","modified_gmt":"2013-05-07T12:28:39","slug":"noves-perspectives-al-tractament-del-cancer-de-prostata","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2013\/05\/07\/noves-perspectives-al-tractament-del-cancer-de-prostata\/","title":{"rendered":"Nuevas perspectivas en el tratamiento del c\u00e1ncer de pr\u00f3stata"},"content":{"rendered":"<p>Esta actividad, organizada por la Sociedad Catalana de Farmacia Cl\u00ednic<a href=\"http:\/\/blog.cofb.cat\/noves-perspectives-al-tractament-del-cancer-de-prostata\/curs-cancerprostata-130425-07\/\" rel=\"attachment wp-att-1436\"><img decoding=\"async\" class=\"wp-image-1436 alignright\" alt=\"curs-cancerprostata-130425-07\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2013\/05\/curs-cancerprostata-130425-07.jpg\" width=\"248\" height=\"166\" \/><\/a>a (SCFC) y el Colegio, pretend\u00eda profundizar en el conocimiento de las nuevas estrategias y alternativas terap\u00e9uticas para tratar el c\u00e1ncer de pr\u00f3stata con el fin de conseguir una mayor eficacia en menos tiempo. El c\u00e1ncer de pr\u00f3stata <strong>es el c\u00e1ncer urol\u00f3gico m\u00e1s corriente entre la poblaci\u00f3n masculina espa\u00f1ola y actualmente la segunda causa de muerte por enfermedad tumoral en hombres<\/strong> despu\u00e9s del c\u00e1ncer de pulm\u00f3n.<\/p>\n<p><a href=\"http:\/\/blog.cofb.cat\/noves-perspectives-al-tractament-del-cancer-de-prostata\/curs-cancerprostata-130425-01\/\" rel=\"attachment wp-att-1435\"><img fetchpriority=\"high\" decoding=\"async\" class=\"alignleft  wp-image-1435\" alt=\"curs-cancerprostata-130425-01\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2013\/05\/curs-cancerprostata-130425-01.jpg\" width=\"184\" height=\"275\" \/><\/a>El curso, realizado el 25 de abril en la sede colegial, iba dirigido a farmac\u00e9uticos de hospitales, de centros de atenci\u00f3n primaria y de la administraci\u00f3n sanitaria.<\/p>\n<p>En el equipo docente participaron\u00a0<b>Natalia<\/b> <b>Cruces, <\/b>farmac\u00e9utica adjunta del Servicio de Farmacia, \u00c1rea Onco-Hematolog\u00eda, del Hospital Cl\u00ednic de Barcelona; <b>Jordi<\/b> <b>Gin\u00e9s, <\/b>farmac\u00e9utico adjunto del Servicio de Farmacia, \u00c1rea Onco-Hematolog\u00eda, del Hospital Universitario Son Espases de Palma de Mallorca; <b>Cristina Mart\u00edn, <\/b>m\u00e9dico adjunto del Servicio de Oncolog\u00eda M\u00e9dica de Hospital de la Santa Cruz y San Pablo de Barcelona, y <strong>Estela Moreno<\/strong>, farmac\u00e9utica adjunta del Servicio de Farmacia, \u00c1rea Onco-hematolog\u00eda, de Hospital de la Santa Cruz y San Pablo.<\/p>\n<p><strong>Tom\u00e1s Casas\u00edn<\/strong>, vocal de Hospitales del COF de Barcelona, y <strong>Julio Martinez<\/strong>, presidente de la SCFC, coordinaron el curso, patrocinado por Janssen.<\/p>","protected":false},"excerpt":{"rendered":"<p>Esta actividad, organizada por la Sociedad Catalana de Farmacia Cl\u00ednica (SCFC) y el Colegio, pretend\u00eda profundizar en el conocimiento de las nuevas estrategias y alternativas terap\u00e9uticas para tratar el c\u00e1ncer de pr\u00f3stata con el fin de conseguir una mayor eficacia en menos tiempo. El c\u00e1ncer de pr\u00f3stata es el c\u00e1ncer urol\u00f3gico m\u00e1s [\u2026]<\/p>","protected":false},"author":1,"featured_media":1436,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[70,481],"class_list":["post-1430","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-formacio","tag-hospitals"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Noves perspectives al tractament del c\u00e0ncer de pr\u00f2stata - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2013\/05\/07\/noves-perspectives-al-tractament-del-cancer-de-prostata\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Noves perspectives al tractament del c\u00e0ncer de pr\u00f2stata - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"Aquesta activitat, organitzada per la Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC) i el Col\u00b7legi, pretenia aprofundir en el coneixement de les noves estrat\u00e8gies i alternatives terap\u00e8utiques per tractar el c\u00e0ncer de pr\u00f2stata amb la finalitat d&#8217;aconseguir m\u00e9s efic\u00e0cia en menys temps. El c\u00e0ncer de pr\u00f2stata \u00e9s el c\u00e0ncer urol\u00f2gic m\u00e9s [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2013\/05\/07\/noves-perspectives-al-tractament-del-cancer-de-prostata\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2013-05-07T12:28:39+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/05\/07\/noves-perspectives-al-tractament-del-cancer-de-prostata\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/05\/07\/noves-perspectives-al-tractament-del-cancer-de-prostata\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Noves perspectives al tractament del c\u00e0ncer de pr\u00f2stata\",\"datePublished\":\"2013-05-07T12:28:39+00:00\",\"dateModified\":\"2013-05-07T12:28:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/05\/07\/noves-perspectives-al-tractament-del-cancer-de-prostata\/\"},\"wordCount\":248,\"commentCount\":2,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/05\/07\/noves-perspectives-al-tractament-del-cancer-de-prostata\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Formaci\u00f3\",\"Hospitals\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2013\/05\/07\/noves-perspectives-al-tractament-del-cancer-de-prostata\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/05\/07\/noves-perspectives-al-tractament-del-cancer-de-prostata\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2013\/05\/07\/noves-perspectives-al-tractament-del-cancer-de-prostata\/\",\"name\":\"Noves perspectives al tractament del c\u00e0ncer de pr\u00f2stata - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/05\/07\/noves-perspectives-al-tractament-del-cancer-de-prostata\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/05\/07\/noves-perspectives-al-tractament-del-cancer-de-prostata\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2013-05-07T12:28:39+00:00\",\"dateModified\":\"2013-05-07T12:28:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/05\/07\/noves-perspectives-al-tractament-del-cancer-de-prostata\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2013\/05\/07\/noves-perspectives-al-tractament-del-cancer-de-prostata\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/05\/07\/noves-perspectives-al-tractament-del-cancer-de-prostata\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/05\/07\/noves-perspectives-al-tractament-del-cancer-de-prostata\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Noves perspectives al tractament del c\u00e0ncer de pr\u00f2stata\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Noves perspectives al tractament del c\u00e0ncer de pr\u00f2stata - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2013\/05\/07\/noves-perspectives-al-tractament-del-cancer-de-prostata\/","og_locale":"es_ES","og_type":"article","og_title":"Noves perspectives al tractament del c\u00e0ncer de pr\u00f2stata - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"Aquesta activitat, organitzada per la Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC) i el Col\u00b7legi, pretenia aprofundir en el coneixement de les noves estrat\u00e8gies i alternatives terap\u00e8utiques per tractar el c\u00e0ncer de pr\u00f2stata amb la finalitat d&#8217;aconseguir m\u00e9s efic\u00e0cia en menys temps. El c\u00e0ncer de pr\u00f2stata \u00e9s el c\u00e0ncer urol\u00f2gic m\u00e9s [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2013\/05\/07\/noves-perspectives-al-tractament-del-cancer-de-prostata\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2013-05-07T12:28:39+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"wpAdminCofbOrg","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2013\/05\/07\/noves-perspectives-al-tractament-del-cancer-de-prostata\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2013\/05\/07\/noves-perspectives-al-tractament-del-cancer-de-prostata\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Noves perspectives al tractament del c\u00e0ncer de pr\u00f2stata","datePublished":"2013-05-07T12:28:39+00:00","dateModified":"2013-05-07T12:28:39+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2013\/05\/07\/noves-perspectives-al-tractament-del-cancer-de-prostata\/"},"wordCount":248,"commentCount":2,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2013\/05\/07\/noves-perspectives-al-tractament-del-cancer-de-prostata\/#primaryimage"},"thumbnailUrl":"","keywords":["Formaci\u00f3","Hospitals"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2013\/05\/07\/noves-perspectives-al-tractament-del-cancer-de-prostata\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2013\/05\/07\/noves-perspectives-al-tractament-del-cancer-de-prostata\/","url":"https:\/\/novaorg.cofb.net\/2013\/05\/07\/noves-perspectives-al-tractament-del-cancer-de-prostata\/","name":"Noves perspectives al tractament del c\u00e0ncer de pr\u00f2stata - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2013\/05\/07\/noves-perspectives-al-tractament-del-cancer-de-prostata\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2013\/05\/07\/noves-perspectives-al-tractament-del-cancer-de-prostata\/#primaryimage"},"thumbnailUrl":"","datePublished":"2013-05-07T12:28:39+00:00","dateModified":"2013-05-07T12:28:39+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2013\/05\/07\/noves-perspectives-al-tractament-del-cancer-de-prostata\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2013\/05\/07\/noves-perspectives-al-tractament-del-cancer-de-prostata\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/novaorg.cofb.net\/2013\/05\/07\/noves-perspectives-al-tractament-del-cancer-de-prostata\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2013\/05\/07\/noves-perspectives-al-tractament-del-cancer-de-prostata\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Noves perspectives al tractament del c\u00e0ncer de pr\u00f2stata"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"},"uagb_comment_info":3,"uagb_excerpt":"Aquesta activitat, organitzada per la Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC) i el Col\u00b7legi, pretenia aprofundir en el coneixement de les noves estrat\u00e8gies i alternatives terap\u00e8utiques per tractar el c\u00e0ncer de pr\u00f2stata amb la finalitat d&#8217;aconseguir m\u00e9s efic\u00e0cia en menys temps. El c\u00e0ncer de pr\u00f2stata \u00e9s el c\u00e0ncer urol\u00f2gic m\u00e9s [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/1430","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=1430"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/1430\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=1430"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=1430"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=1430"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}